ADMINISTRATION OF HORMONAL ADD-BACK THERAPY (ABT) COUNTERACTS THE UTERINE VOLUME REDUCING EFFECTS OF ORAL GnRH ANTAGONIST THERAPY

To assess the effect of administration of ABT (estradiol (E2) 1mg/norethindrone acetate 0.5 mg) on uterine volume in women with symptomatic uterine fibroids (UF) receiving the oral GnRH antagonist, linzagolix (LGX).

Source: Fertility and Sterility - September 1, 2021 Category: Reproduction Medicine Authors: Jacques Donnez, Hugh S. Taylor, William Catherino, Ayman Al-Hendy, Elke Bestel, Andrew Humberstone, Elizabeth Garner Source Type: research